Patents Examined by Saumel C Woolwine
  • Patent number: 10138519
    Abstract: Described herein are methods, compositions and kits directed to amplification of nucleic acids suitable for both next generation sequencing (NGS) and a second round of sequencing as validation, such as Sanger sequencing.
    Type: Grant
    Filed: December 27, 2013
    Date of Patent: November 27, 2018
    Assignee: Quest Diagnostics Investments Incorporated
    Inventors: Heather Sanders, Hai-Rong Li, Feras Hantash, Frederic Waldman